These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 803804)

  • 21. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectious bovine keratoconjunctivitis: comparison of infection, signs of disease and weight gain in vaccinated versus nonvaccinated purebred Hereford heifer calves.
    Pugh GW; McDonald TJ; Kopecky KE; Kvasnicka WG
    Can J Vet Res; 1986 Apr; 50(2):259-64. PubMed ID: 3756679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimentally induced infectious bovine keratoconjunctivitis: potentiation of a Moraxella bovis pilus vaccine's immunogenicity by vaccination with Mycobacterium paratuberculosis bacterin.
    Pugh GW; McDonald TJ; Larsen AB
    Am J Vet Res; 1978 Oct; 39(10):1656-61. PubMed ID: 717879
    [No Abstract]   [Full Text] [Related]  

  • 25. Bovine infectious keratoconjunctivitis: carrier state of Moraxella bovis and the development of preventive measures against disease.
    Pugh GW; Hughes DE
    J Am Vet Med Assoc; 1975 Aug; 167(4):310-3. PubMed ID: 1097382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious bovine keratoconjunctivitis: evidence for general immunity.
    Kopecky KE; Pugh GW; McDonald TJ
    Am J Vet Res; 1983 Feb; 44(2):260-2. PubMed ID: 6830015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wavelength of ultraviolet radiation that enhances onset of clinical infectious bovine keratoconjunctivitis.
    Kopecky KE; Pugh GW; Hughes DE
    Am J Vet Res; 1980 Sep; 41(9):1412-5. PubMed ID: 7447134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infectious bovine keratoconjunctivitis: comparison of a fluorescent antibody technique and cultural isolation for the detection of Moraxella bovis in eye secretions.
    Pugh GW; Hughes DE; Kohlmeier RH; Wallace JR; Graham CK
    Am J Vet Res; 1977 Sep; 38(9):1349-52. PubMed ID: 335929
    [No Abstract]   [Full Text] [Related]  

  • 29. Infectious bovine keratoconjunctivitis I. Experimental production.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):22-31. PubMed ID: 163126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimentally induced bovine infectious keratoconjunctivitis: effectiveness of intramuscular vaccination with viable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1971 Jun; 32(6):879-86. PubMed ID: 4997447
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens.
    Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH
    Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of florfenicol in the treatment of experimentally induced infectious bovine keratoconjunctivitis.
    Dueger EL; Angelos JA; Cosgrove S; Johnson J; George LW
    Am J Vet Res; 1999 Aug; 60(8):960-4. PubMed ID: 10451205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation.
    Smith JA; George LW
    Am J Vet Res; 1985 Apr; 46(4):804-7. PubMed ID: 4014830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections.
    Lane VM; George LW; Cleaver DM
    J Am Vet Med Assoc; 2006 Aug; 229(4):557-61. PubMed ID: 16910856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.